Eisai
4523.T
#2180
Rank
C$11.74 B
Marketcap
C$41.63
Share price
0.34%
Change (1 day)
0.59%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$5.22 Billion

According to Eisai's latest financial reports the company's total liabilities are C$5.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31C$4.99 B13.07%
2024-03-31C$4.41 B-1.17%
2023-03-31C$4.47 B-6.87%
2022-03-31C$4.80 B16.9%
2021-03-31C$4.10 B-12.75%
2020-03-31C$4.70 B-6.68%
2019-03-31C$5.04 B-4.36%
2018-03-31C$5.27 B2.99%
2017-03-31C$5.12 B11.65%
2016-03-31C$4.58 B-3.95%
2015-03-31C$4.77 B0.36%
2014-03-31C$4.75 B-14.5%
2013-03-31C$5.56 B-20.54%
2012-03-31C$7.00 B-5.32%
2011-03-31C$7.39 B1.23%
2010-03-31C$7.30 B-19.85%
2009-03-31C$9.11 B37.21%
2008-03-31C$6.64 B194.67%
2007-03-31C$2.25 B-0.98%
2006-03-31C$2.27 B-0.52%
2005-03-31C$2.28 B-7.47%
2004-03-31C$2.47 B-2.5%
2003-03-31C$2.53 B13.77%
2002-03-31C$2.23 B-12.08%
2001-03-31C$2.53 B